The B cell immune response in the elderly is characterized by the production of low affinity antibodies and by the production of autoreactive antibodies. This results in diminished protection against infections and in increased incidence of autoimmune diseases in the elderly. Defects in the immune response have been extensively studied in the mouse. Little is known, however, about B cell defects in the human. Here, we propose to analyze defects in the human humoral immune response. In particular, we want to analyze defects associated with affinity maturation in the elderly. First, we will determine whether defects involve B cell development by analyzing B cell subpopulations in tonsils. Additionally, antibodies expressed by these various subpopulations will be sequenced and Vh gene utilization will be analyzed. Data on B cell subpopulations and antibody sequences will be compared to data previously obtained in similar conditions from young adult tonsils. Second, we will determine whether defects are at the B and/or T cell level by analyzing the ability of B and T cells from the elderly to mediate somatic mutation. For this, we will use an in vitro assay. Third, we will determine whether aging influences immunoglobulin gene segment utilization and antigenic selection using a human immunoglobulin heavy chain transgenic mini-locus model we developed. This project is likely to provide important information on the defects involved in antibody repertoire shaping in aging humans. The research will complement that in Project III which will analyze defects in early B cell development in elderly humans and is consistent with the overall Program Project theme of lymphocyte development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI045864-01
Application #
6228584
Study Section
Special Emphasis Panel (ZAI1-SCO-I (M1))
Project Start
1999-09-30
Project End
2003-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Joachims, Michelle L; Chain, Jennifer L; Hooker, Scott W et al. (2006) Human alpha beta and gamma delta thymocyte development: TCR gene rearrangements, intracellular TCR beta expression, and gamma delta developmental potential--differences between men and mice. J Immunol 176:1543-52
Yokota, Takafumi; Huang, Jiaxue; Tavian, Manuela et al. (2006) Tracing the first waves of lymphopoiesis in mice. Development 133:2041-51
Igarashi, Hideya; Medina, Kay L; Yokota, Takafumi et al. (2005) Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. Int Immunol 17:501-11
Rajaiya, Jaya; Hatfield, Melissa; Nixon, Jamee C et al. (2005) Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright. Mol Cell Biol 25:2073-84
Chain, J L; Joachims, M L; Hooker, S W et al. (2005) Real-time PCR method for the quantitative analysis of human T-cell receptor gamma and beta gene rearrangements. J Immunol Methods 300:12-23
Yao, Longbiao; Yokota, Takafumi; Xia, Lijun et al. (2005) Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells. Blood 106:4093-101
Kolar, G R; Capra, J D (2004) Immunoglobulin heavy-chain receptor editing is observed in the NOD/SCID model of human B-cell development. Scand J Immunol 60:108-11
Nixon, Jamee C; Rajaiya, Jaya; Webb, Carol F (2004) Mutations in the DNA-binding domain of the transcription factor Bright act as dominant negative proteins and interfere with immunoglobulin transactivation. J Biol Chem 279:52465-72
Nixon, Jamee C; Rajaiya, Jaya B; Ayers, Neil et al. (2004) The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations. Cell Immunol 228:42-53
Kolar, Grant R; Yokota, Takafumi; Rossi, Maria Isabel D et al. (2004) Human fetal, cord blood, and adult lymphocyte progenitors have similar potential for generating B cells with a diverse immunoglobulin repertoire. Blood 104:2981-7

Showing the most recent 10 out of 20 publications